| ▲ | nottorp 13 hours ago | |||||||
Self approval? Like Boeing? | ||||||||
| ▲ | canucker2016 10 hours ago | parent | next [-] | |||||||
Is Boeing terminally ill? </rhetorical> Jake Seliger, HNer, jseliger - https://news.ycombinator.com/user?id=jseliger, who died a couple of years ago, had exhausted the current standards of treatment for head-neck cancer. Drugs available through clinical trials were his last option. But the workflow to access drugs via clinical trial is terrible. Directions/Instructions aren't documented. Unwritten limitations and optimizations. Jake and his wife documented his path through the process. see https://jakeseliger.com/2023/07/22/i-am-dying-of-squamous-ce... also see https://jakeseliger.com/tag/clinical-trials/ and https://bessstillman.substack.com/t/clinical-trial Also read https://bessstillman.substack.com/p/the-seliger-act-testimon... for a literal post-mortem view of the clinical drug trial process. | ||||||||
| ||||||||
| ▲ | inglor_cz 12 hours ago | parent | prev [-] | |||||||
Not self-approval, but maybe look at the clinical trial reforms in China (2016). There seems to be a lesson there to learn from. They made the trial system a lot more flexible, and China has recently overtaken the US in the # of new drugs patented, about a third worldwide. That number was ~ zero mere ten years ago. | ||||||||